Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue

Carl G. Groth, William E. Hathaway, Åke Gustafsson, W. Peter Geis, Charles W. Putnam, Christer Björkén, K. A. Porter, Thomas E. Starzl

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Available data concerning the non-hepatic source of plasma factor VIII are conflicting. In the present study, dogs with factor VIII deficiency hemophilia were transplanted with spleen or vascularized lymph node grafts obtained from normal donor dogs. Postoperative immunosuppression was done with azathioprine and heterologous antilymphocyte globulin. Four spleen transplants were successful and the recipients had positive technetium sulfide spleen scans along with adequate plasma factor VIII levels for three to eight weeks. Cessation of graft isotope uptake was accompanied by prompt disappearance of plasma factor in all four dogs. Histologically, the grafts were rejected at this time. In one dog, a second spleen graft immediately restored therapeutic factor VIII levels. Four lymph node transplants were successful and plasma factor VIII was detected for one, one, two, and ten weeks. Three dogs rejected their lymph node grafts with disappearance of factor VIII, while one had a viable transplant removed with loss of factor VIII within two days. The data suggest that factor VIII is produced in the lymphatic tissue of the dog.

Original languageEnglish (US)
Pages (from-to)725-733
Number of pages9
Issue number5
StatePublished - May 1974
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue'. Together they form a unique fingerprint.

Cite this